AI-generated summary
The authors randomized 23 patients with burning mouth syndrome to active or inactive low level laser therapy at 685 nm for ten sessions. Both groups showed lower burning scores and salivary cortisol after treatment, and the authors report that LLLT may help but say larger studies are needed to separate laser effect from placebo effect.
- Participants
- 23
- Who or what was studied
- Patients with burning mouth syndrome
- Wavelengths
- 685 nm
- Limits stated in the abstract
- Small sample of 23 patients split into two groups of 11 and 12, and the authors state that larger studies are needed to determine whether results reflect laser effectiveness or placebo effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on hrcak.srce.hr.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 685nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Visual analogue scale, Light-emitting diode, Placebo effect, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.